“Cardiabetes”: Is It Time for a New Subspecialty?
With a growing number of patients with both diabetes and cardiovascular disease, clinicians consider the need for a new specialty: cardiometabolic medicine.
Rachael Beairsto
rachael.beairsto@haymarketmedia.com https://www.endocrinologyadvisor.com/
Rachael Beairsto is a medical editor with Haymarket Media, Inc, overseeing all things related to hormone health at Endocrinology Advisor. She holds a BS in biology from Northeastern University in Boston, Massachusetts. Prior to joining Haymarket in 2018, Rachael worked at Ogilvy in a healthcare communications role and at Sanofi in a market research group supporting the marketing of established medications within the biosurgery and renal disease spaces.
